Mike Zaranek Form 4 Science 37 / Mike Zaranek ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Zaranek Mike

(Last) (First) (Middle)

800 PARK OFFICES DRIVE, SUITE 3606

(Street)

RESEARCH TRIANGLE PARK NC 27709

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Science 37 Holdings, Inc. [ SNCE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
04/28/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/28/2023		A		444,283	A	(1)(2)(3)	444,283(4)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$9.06	04/28/2023		D			457,466(5)	(1)	06/13/2031	Common Stock	457,466	(1)	0	D
Stock Option	$11.47	04/28/2023		D			185,897	(2)	01/07/2032	Common Stock	185,897	(2)	0	D
Stock Option	$10.05	04/28/2023		D			467,351	(3)	10/07/2031	Common Stock	467,351	(3)	0	D

Explanation of Responses:

1. On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 457,466 shares of common stock of the issuer and in exchange issued to the reporting person 182,985 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.

2. On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 185,897 shares of common stock of the issuer and in exchange issued to the reporting person 74,358 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.

3. On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 467,351 shares of common stock of the issuer and in exchange issued to the reporting person 186,940 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock.

4. Includes 444,283 restricted stock units, which will vest in three equal annual installments beginning on April 28, 2024, subject to continued employment.

5. The total amount has been adjusted to add 11 derivative securities that were not previously included due to a rounding error.

Remarks:

	/s/ Christine Pellizzari, Attorney-in-Fact for Mike Zaranek	05/02/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.